MED12somatic mutations in fibroadenomas and phyllodes tumours of the breast

Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors

(2015) Andi K. Cani et al.   MOLECULAR CANCER RESEARCH

MED12 exon 2 mutations are common in uterine leiomyomas from South African patients

(2015) Netta Mäkinen et al.   Oncotarget

Mutations in Exon 1 Highlight the Role ofMED12in Uterine Leiomyomas

(2014) Kati Kämpjärvi et al.   HUMAN MUTATION

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

(2014) Rachael Natrajan et al.   JOURNAL OF PATHOLOGY

MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma

(2014) Elizabeth Bertsch et al.   MODERN PATHOLOGY

Integrated genomic characterization of adrenocortical carcinoma

(2014) Guillaume Assié et al.   NATURE GENETICS

Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands

(2014) Ilan Weinreb et al.   NATURE GENETICS

Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma

(2014) Weng Khong Lim et al.   NATURE GENETICS

Uterine Leiomyoma-Linked MED12 Mutations Disrupt Mediator-Associated CDK Activity

(2014) Mikko Turunen et al.   Cell Reports

MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors

(2013) Katherine E. Schwetye et al.   HUMAN PATHOLOGY

Characterization of Uterine Leiomyomas by Whole-Genome Sequencing

(2013) Miika Mehine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer

(2012) K Kämpjärvi et al.   BRITISH JOURNAL OF CANCER

MED12mutations occurring in benign and malignant mammalian smooth muscle tumors

(2012) Dominique Nadine Markowski et al.   GENES CHROMOSOMES & CANCER

Prevalence ofMED12mutations in uterine and extrauterine smooth muscle tumours

(2012) Akiko Matsubara et al.   HISTOPATHOLOGY

Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors

(2012) Eun Mi Je et al.   INTERNATIONAL JOURNAL OF CANCER

MED12 mutations in leiomyosarcoma and extrauterine leiomyoma

(2012) Gloria Ravegnini et al.   MODERN PATHOLOGY

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

(2012) Christopher E Barbieri et al.   NATURE GENETICS

Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas

(2012) Megan M. McGuire et al.   PLoS One

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas

(2011) N. Makinen et al.   SCIENCE

Interactions between subunits of the Mediator complex with gene-specific transcription factors

(2011) Tilman Borggrefe et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY